Definitive Contract 75D30121C12877
- Not listed
- This is a definitive cost-reimbursement contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to the Denver Health and Hospital Authority (Denver Health) for the Tuberculosis Trials Consortium (TBTC). The contract, which does not have a set-aside designation, has a potential value of $311,831.31 and a completion date of October 9, 2022. As a 555-bed academic health system and the region's only Level I trauma center, Denver Health...
- The U.S. Department of Health and Human Services (HHS) awarded a $5,099,064.36 delivery order contract to Denver Health and Hospital Authority (Denver Health) to conduct a study comparing tuberculosis skin tests (TST) and interferon-gamma release assays (IGRAs) in latent tuberculosis infection (LTBI) patients. The contract was issued under the Tuberculosis Epidemiology Studies Consortium, a larger indefinite delivery vehicle held by HHS. The award did not utilize any set-aside designations....
- Duke University, as prime contractor, was awarded a $4.3 million delivery order against the Tuberculosis Epidemiology Studies Consortium master IDIQ by the Centers for Disease Control and Prevention. The contract calls for enrollment, preventive treatment, data collection and analysis of latent tuberculosis infection patients. Major subcontractors include Atrium Health and Vanderbilt University, which will assist with performance of the clinical work. The goal of the project appears to be...
- This federal contract award to Kaiser Foundation Hospitals, a subsidiary of Kaiser Foundation Health Plan, Inc., supports the Centers for Disease Control and Prevention's (CDC) efforts to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The $5,223,415 definitive contract, awarded on September 29, 2021 without a set-aside, will fund the development, implementation, and evaluation of LTBI intervention...
- This $3,015,216.50 Delivery Order contract was awarded to Denver Health and Hospital Authority (Denver Health) by the Centers for Disease Control and Prevention (CDC) to provide Vaccine Safety Datalink (VSD) services. The VSD is an IDIQ contract vehicle managed by the CDC to support ongoing vaccine safety monitoring and research. This award does not have a set-aside designation. As a 555-bed academic health system and the region's only Level I trauma center, Denver Health provides...
- This is a $5,176,985.37 cost-no-fee definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to King County, doing business as Public Health-Seattle & King County. The contract is to develop, implement, and evaluate interventions to improve identification and treatment of latent tuberculosis infection (LTBI) among high-risk non-U.S.-born populations in primary care settings. The contract is part of the TBESC 3 - Seattle and King County program and does not have a...
- The Centers for Disease Control and Prevention (CDC) awarded a $376,692 delivery order contract to the Colorado Department of Public Health & Environment (CDPHE) to provide National Center for Health Statistics Vital Statistics Cooperative Program (NCHS VSCP) services. As the prime contractor, CDPHE will perform the work in Denver, Colorado from February 22, 2023 through May 1, 2024 under a firm fixed price arrangement. The CDPHE, a department of the City of Lakewood, will utilize...
- This is a $1,353,024.00 firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to the Denver Health and Hospital Authority, doing business as Denver Health, to harness diverse data through information sciences to improve health outcomes, evaluate bias, recruitment, and retention in an online setting, conduct a recruitment and retention optimization study, and perform content validation of questionnaire modules. The contract supports a pilot study for these...
- This federal contract award, with ID HHSD200201692277C, was issued by the Centers for Disease Control and Prevention (CDC) to the University of Colorado-Denver, doing business as The Regents of the University of Colorado, for the UTIDECIDE program. The $249,708 firm fixed-price definitive contract has an ultimate completion date of September 19, 2017 and was awarded on September 13, 2016. The contract does not have a set-aside designation. The University of Colorado-Denver is a major public...
- This contract award, valued at $384,692.00, was issued by the Centers for Disease Control and Prevention (CDC) to the Colorado Department of Public Health & Environment (CDPHE) as a delivery order. The contract is not set aside and is for CDPHE to provide vital statistics data collection and reporting services to support national health surveillance efforts under the Vital Statistics Cooperative Program. CDPHE holds a larger $7.67 million single-award Indefinite Delivery Vehicle (IDV) from...
The Centers for Disease Control and Prevention (CDC) awarded a $4,679,587.20 Definitive Contract to the Denver Health and Hospital Authority (Denver Health) to develop, implement, and evaluate intervention studies to improve identification of latent tuberculosis infection (LTBI) and treatment-to-cure for high-risk non-U.S.-born populations in primary care settings. This contract, which does not have a set-aside designation, has a period of performance from September 29, 2021 through March 28, 2026. Denver Health, a comprehensive 555-bed academic healthcare system in Denver, Colorado, has extensive experience supporting federal healthcare and research objectives, including multiple Indefinite Delivery Vehicle (IDV) contracts with the CDC and Food and Drug Administration (FDA) for vaccine safety monitoring, drug use surveillance, and data analytics. This contract aligns with the CDC's broader efforts to address tuberculosis infection among high-risk populations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00013 | Supplemental Agreement for work within scope | $0 | 6/5/25 | |
| P00012 | Terminate for Convenience | $0 | 4/23/25 | |
| P00011 | Exercise an Option | $1.2m | 3/26/25 | |
| P00010 | Other Administrative Action | ($611k) | 6/17/24 | |
| P00008 | Exercise an Option | $1.2m | 3/19/24 |